Matinas Biopharma Holdings Inc. - Debt To Equity Ratio (Historical) - MarketXLS
Data
Debt To Equity Ratio (Historical)
LiveIt is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity. It is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds
How calculated | Debt / Equity= Total Liabilities / Total Shareholders’ Equity
|
Example usage | =hf_Debt_to_Equity_Ratio("MSFT",2022) - Returns the value for the year 2022. =hf_Debt_to_Equity_Ratio("MSFT",2022,2) - Returns the value for the year 2022 and the calendar quarter 2 =hf_Debt_to_Equity_Ratio("MSFT",2022,3,"TTM") - Returns the value for the year 2022 and trailing twelve months from the calendar quarter =hf_Debt_to_Equity_Ratio("MSFT","lq") - Returns the value for the last quarter =hf_Debt_to_Equity_Ratio("MSFT","lq-1") - Returns the value for the last quarter-1 =hf_Debt_to_Equity_Ratio("MSFT","ly") - Returns the value for the last year =hf_Debt_to_Equity_Ratio("MSFT","ly-1") - Returns the value for the last year - 1 =hf_Debt_to_Equity_Ratio("MSFT","lt") - Returns the value for the last 12 months. =hf_Debt_to_Equity_Ratio("MSFT","lt-1") - Returns the value for the previous last 12 months. |
Notes | A “good” debt-to-equity (D/E) ratio will depend on the nature of the business and its industry. Generally speaking, a D/E ratio below 1.0 would be seen as relatively safe, whereas ratios of 2.0 or higher would be considered risky.
Some industries, such as banking, are known for having much higher D/E ratios than others. Note that a D/E ratio that is too low may actually be a negative signal, indicating that the firm is not taking advantage of debt financing to expand and grow |
Assets | Stocks |
| Stock | Debt To Equity Ratio (Historical) |
|---|
Matinas Biopharma Holdings Inc.
MTNB 
AMX
Sector: Healthcare
Industry: Biotechnology
0.62
USD
0.04
(6.21%)
Previous close: 0.5799 Open: 0.5625 Bid: 0.59 Ask: 0.6
52 week range
0.50 21.50
Mkt Cap: 3 M Avg Vol (90 Days): 208,767
Last updated: Sunday 24th November 2024
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS is a complete Excel stock solution
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel
MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.
I like to access historical closing prices on a particular date. That makes tracking performance easy.